Target intelligence / Profile preview

23S ribosomal RNA (23S rRNA) (23S rRNA)

Target
23S rRNA
Molecular classification
Ribozyme, Enzyme, Other
01

Overview

The 23S ribosomal RNA (23S rRNA) is the catalytic core of the 50S large ribosomal subunit in bacteria, functioning as a ribozyme that facilitates protein synthesis. It contains the peptidyl transferase center (PTC), which is responsible for catalyzing the formation of peptide bonds between amino acids during translation elongation. By providing the structural framework for the A-site and P-site tRNA binding, the 23S rRNA ensures the correct positioning of substrates for the nucleophilic attack necessary for polypeptide growth. This molecule is a critical therapeutic target for numerous classes of antibiotics, including macrolides, oxazolidinones, lincosamides, and pleuromutilins. These drugs typically bind to the PTC or the adjacent nascent peptide exit tunnel (NPET), effectively halting bacterial growth by obstructing the passage of the emerging protein or inhibiting the catalytic activity of the ribosome. Resistance to these antibiotics often arises through specific point mutations in the 23S rRNA sequence or through enzymatic modification, such as methylation by Erm-class methyltransferases. Because human mitochondrial ribosomes share structural similarities with bacterial ribosomes, some drugs targeting the 23S rRNA can lead to off-target toxicity, such as myelosuppression or neuropathy, due to the inhibition of mitochondrial protein synthesis.

Other names
Peptidyl transferase centerPTC50S ribosomal RNALarge subunit ribosomal RNA
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the peptidyl transferase center or the nascent peptide exit tunnel, thereby preventing peptide bond formation or polypeptide elongation.

03

Biological functions

Protein synthesisPeptidyl transferase activityTranslation elongationOther
04

Disease associations

Infection
05

Safety considerations

Mitochondrial protein synthesis inhibitionMyelosuppressionAntibiotic resistanceGastrointestinal dysbiosis
06

Interacting drugs

9 more in the full profile.

07

Biomarkers

23S rRNA A2058 mutation23S rRNA A2059 mutationCfr methyltransferase expressionErm methylase expression

Beyond the preview

Go deeper on 23S ribosomal RNA (23S rRNA) (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA (23S rRNA) (23S rRNA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call